SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

ABCL is currently seeing high volatility and heavy trading volume as investors debate its long-term potential following recent clinical trial data and a significant partnership with Jazz Pharmaceuticals. The community is sharply divided between "long" shareholders who view recent price dips as an accumulation opportunity and vocal critics who argue the company has failed to deliver consistent returns over the past five years.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors monitor a critical court hearing regarding the distribution rights for its lead DMD therapy, alongside growing optimism that the FDAs recent shift toward more transparent, rare-disease-friendly reviews could pave the way for a swift, broad label approval ahead of the PDUFA date. The community is heavily focused on the potential for an injunction against its commercial partner to resolve distribution hurdles, while actively debating the impact of upcoming five-year clinical data and the broader regulatory environment on the stock's valuation.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF is trending as investors rotate into defensive, income-focused positions amid broader market uncertainty. Community discourse centers on the ETF's role as a stable portfolio anchor for long-term compounding, with active discussions regarding dividend growth consistency, reconstitution updates, and strategic buying opportunities.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to reports of a Japanese government delegation planning to explore rare-earth mining opportunities in Greenland, a region where the company controls a major stake in the Tanbreez Project. Community discussion is heavily focused on potential geopolitical tailwinds, the company's progress toward production, and active debates over the stock's valuation, share dilution, and the timing of upcoming project updates.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is facing significant downward pressure following the release of incomplete May sales data, which has exacerbated investor concerns and fueled speculation regarding competitive threats from AstraZeneca's Ultomiris. Despite the negative price action, the community is actively debating the reliability of these sales metrics and looking toward upcoming regulatory milestones, including EMA developments and the activation of the J-Code, as potential catalysts for a recovery.

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

Ardelyx shares are currently experiencing volatility as investors weigh strong IBSRELA revenue growth against the ongoing uncertainty surrounding a CMS court ruling and management's aggressive spending strategy. While the community is debating potential M&A rumors and the long-term impact of pending legal outcomes, active traders are closely monitoring institutional volume and support levels while awaiting a definitive catalyst to break the current consolidation pattern.

Apogee Therapeutics, Inc. is a clinical stage biotechnology company. It offers treatment of atopic dermatitis (AD), ashma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded by Andrew Gottesdiener and Nimish P. Shah in 2022 and is headquartered in Waltham, MA.

Apogee Therapeutics Inc.

Apogee Therapeutics

Apogee Therapeutics is trending following a massive multi-billion dollar acquisition deal by AbbVie, which investors view as a validation of the biotech firm's immunology pipeline. Community sentiment is high, with market participants debating if the premium buyout signals a broader M&A wave for other immunology-focused companies as big pharma looks to secure high-potential, long-acting assets.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors debate whether the recent sector-wide pullback offers a compelling entry point or signals further downside, with the community actively analyzing management milestones like IM-3 integration against broader concerns of sector rotation and volatility. Traders are focused on upcoming NASA lunar mission updates as a potential catalyst to stabilize price action following a significant correction from recent highs.

USA Rare Earth, Inc. is a domestic supplier of rare earth magnets and heavy rare earth elements. It develops a vertically integrated domestic supply chain for rare earth element magnet production, with a facility in Stillwater and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as investors weigh aggressive government backing, including major CHIPS Act funding and site selection for a massive magnet manufacturing facility, against volatility from the broader rare earth sector and an ongoing legal dispute with MP Materials. Community members are actively debating whether these fundamental tailwinds and defense-critical supply chain integration represent a long-term structural breakout or a high-beta cyclical trade.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased investor focus as analyst upgrades and a pivot toward defensive sector rotation drive positive momentum. The community is actively debating the stock's potential for a long-term recovery to historical highs, with many investors highlighting their strategy of accumulating shares during dips to benefit from consistent dividends and the company's dominant market position.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CorVel Stock Is Down 45%, But This Fund Just Made a $20 Million Move

Key PointsOwls Nest acquired 348,329 shares of CorVel last quarter; the estimated trade size was $20.06 million (based on quarterly average prices...

CorVel (CRVL) Q4 2026 Earnings Call Transcript

CorVel (CRVL) Q4 2026 Earnings Call Transcript...

CorVel Corp. Q4 Profit Climbs

(RTTNews) - CorVel Corp. (CRVL) released earnings for its fourth quarter that Increased, from the same period last year...

M&T Bank Corp Increases Stock Holdings in CorVel Corp. $CRVL

M&T Bank Corp lifted its position in shares of CorVel Corp. (NASDAQ:CRVL - Free Report) by 1,230.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 63,439 shares of the business services provider's stock after buying an additiona...

Boston Trust Walden Corp Has $33.44 Million Stock Position in CorVel Corp. $CRVL

Boston Trust Walden Corp decreased its position in CorVel Corp. (NASDAQ:CRVL - Free Report) by 6.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 494,152 shares of the business services provider's stock after selling 34,930 sha...

CorVel (NASDAQ:CRVL) Share Price Crosses Below 200-Day Moving Average   - What's Next?

CorVel (NASDAQ:CRVL) Shares Pass Below 200 Day Moving Average - Here's Why...

CorVel Insider Sale of $130K Comes Amid 50% One-Year Stock Drop. Here's What Investors Should Know

Key PointsThe chief information officer of Cervel reported selling 2,400 shares for a total of $130,000, based on a weighted average price of $54.00 per share on March 16, 2026...

Argent Capital Management LLC Takes $1.80 Million Position in CorVel Corp. $CRVL

Argent Capital Management LLC purchased a new position in CorVel Corp. (NASDAQ:CRVL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Maxim Shishin Sells 2,400 Shares of CorVel (NASDAQ:CRVL) Stock

CorVel Corp. (NASDAQ:CRVL - Get Free Report) insider Maxim Shishin sold 2,400 shares of the business's stock in a transaction on Monday, March 16th. The stock was sold at an average price of $54.00...

CorVel (NASDAQ:CRVL) Insider Sells $129,600.00 in Stock

CorVel Corp. (NASDAQ:CRVL - Get Free Report) insider Maxim Shishin sold 2,400 shares of the business's stock in a transaction dated Monday, March 16th. The shares were sold at an average price of...

CorVel Corp. engages in the provision of services to employers and payors in the risk management and insurance services arenas, including workers' compensation, general liability, auto liability, and hospital bill auditing and payment integrity. It operates through the Patient Management Services and Network Solutions Services segments. The Patient Management Services segment includes claims administration, utilization review, medical case management, and vocational rehabilitation. The Network Solutions Services segment consists of fee schedule auditing, hospital bill auditing, coordination of independent medical examinations, diagnostic imaging review services, and preferred provider referral services. The company was founded by V. Clemons Gordon Sr. in 1987 and is headquartered in Fort Worth, TX.

Corvel Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CRVLCorvel Corp.

Upcoming Earnings:

Historical Earnings

Latest CRVL News